{"id":203507,"url":"https://lda.senate.gov/api/v1/clients/203507/?format=json","client_id":12,"name":"SAGE THERAPEUTICS","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"MA","state_display":"Massachusetts","country":"US","country_display":"United States of America","ppb_state":"MA","ppb_state_display":"Massachusetts","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2019-05-23","registrant":{"id":401105293,"url":"https://lda.senate.gov/api/v1/registrants/401105293/?format=json","house_registrant_id":null,"name":"SAGE THERAPEUTICS","description":"Pharmaceutical manufacturing","address_1":"55 Cambridge Parkway","address_2":null,"address_3":null,"address_4":null,"city":"Cambridge","state":"MA","state_display":"Massachusetts","zip":"02142","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JULIE GARNER","contact_telephone":"+1 410-456-5210","dt_updated":"2025-07-09T09:43:13.869249-04:00"}}